Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.39 |
| ▸ | CNR2 | P34972 | 3/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13524707 | 0.93 | TP53 (0.54) | TP53TDP1L3MBTL1F2CYP19A1 | |
| SCHEMBL13813876 | 0.93 | TP53 (0.54) | TP53TDP1L3MBTL1F2CYP19A1 | |
| SCHEMBL13814553 | 0.88 | ALDH1A1 (0.43) | TP53ALDH1A1TDP1L3MBTL1F2 | |
| SCHEMBL6547438 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TDP1L3MBTL1F2UTS2R | |
| SCHEMBL7430622 | 0.83 | CYP19A1 (0.46) | ALDH1A1TDP1L3MBTL1F2CYP19A1 | |
| SCHEMBL6546324 | 0.83 | F2 (0.45) | ALDH1A1TDP1L3MBTL1F2CYP19A1 | |
| SCHEMBL29048475 | 0.81 | ALDH1A1 (0.43) | ALDH1A1TDP1L3MBTL1F2UTS2R | |
| SCHEMBL3015704 | 0.81 | ALDH1A1 (0.45) | ALDH1A1TDP1L3MBTL1F2CYP19A1 | |
| SCHEMBL1538332 | 0.78 | CYP19A1 (0.54) | ALDH1A1TDP1CYP19A1KCNH2SMN1; SMN2 | |
| SCHEMBL3009093 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TDP1L3MBTL1F2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156853-A1 | Process for industrially producing dialkyl carbonate and diol | ASAHI KASEI CHEMCIALS CORPORATION (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090137833-A1 | Process for industrially producing dialkyl carbonate and diol | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156853-A1 | Process for industrially producing dialkyl carbonate and diol | ADH1C, IPMK, DCXR | TP53 4701/4885ALDH1A1 1295/4885TDP1 4414/4885 |
| US-20090137833-A1 | Process for industrially producing dialkyl carbonate and diol | ADH1C, IPMK, DCXR | TP53 4701/4885ALDH1A1 1598/4885TDP1 4301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.